Acta Scientific Pharmaceutical Sciences

Mini Review Volume 9 Issue 4

Development of a Polyherbal Nutraceutical Chewable Tablet for Enhancing Skin Radiance and Hair Strengthr

Rishu Kumar1, Anjali Sahu1 and Gyanesh Kumar Sahu2

1Rungta Institute of Pharmaceutical Sciences Kohka, Bhilai, India
2Rungta Institute of Pharmaceutical Sciences and Research Kohka, Bhilai, India

*Corresponding Author: Gyanesh Kumar Sahu, Professor and Dean, Rungta Institute of Pharmaceutical Sciences and Research, Kohka, Kurud, Bhilai, India.

Received: March 05, 2025; Published: March 17, 2025

It examines the composition, advantages, and possible uses of chewable orange, kiwi, and amla pills as natural supplements to support the health of skin and hair. Vitamin C, antioxidants, and other bioactive chemicals found in abundance in orange, kiwi, and amla are essential for enhancing skin suppleness, lowering aging symptoms, and stimulating hair development. For consumers looking for natural and efficient beauty supplements, the chewable tablet format provides a practical and palatable way to provide essential nutrients. These fruits' vitamin C promotes the production of collagen, while their flavonoids and polyphenols offer antioxidant defense against environmental contaminants, UV rays, and oxidative stress. While amla helps prevent premature greying, promote circulation to the scalp, and lessen hair loss, kiwi improves skin hydration, maintains head good health, and increases hair. These chewable pills show promise in meeting the increasing demand from consumers for nutritional supplements in the cosmetics sector, despite issues with flavor masking and the durability of the pharmaceutical components. According to the research, chewable pills of orange, kiwi, and amla may offer a natural and efficient approach to improve the health of skin and hair, giving customers a useful way to enhance their appearance and well-being from the inside out.

Keywords: Composition; Chewable; Vitamin-C; Masking; Appearance

References

  1. Bhatt SK., et al. “THE Role of Chewable Tablets: An Overview: Eprosartan, LC/MS-MS, Validation, Plasma”. Asian Journal of Pharmaceutical Research and Development4 (2021): 141-146.
  2. Dahiya J., et al. “Chewable tablets: a comprehensive review”. The Pharma Innovation5 (2015): 100
  3. Ghurghure SM., et al. “Formulation and evaluation of chewable tablets containing aqueous extract of Zingiber officinale”. World Journal of Pharmacy and Pharmaceutical Sciences 8 (2019): 1-10.
  4. “Haritakyadivarga”. In: Dr. K.C. Chunekar, Translator. Bhavaprakasha Nighantu, Reprint. Varanasi: Chaukhambhabharati academy (2004): 2.
  5. Sai Ram M., et al. “Cytoprotective activity of Amla (Emblica officinalis) against chromium (VI) induced oxidative injury in murine macrophages”. Phytotherapy Research 17 (2003): 430-433.
  6. Al Rehaily AJ., et al. “Gastroprotective effects of ‘Amla’Emblicaofficinalis on in vivo test models in rats”. Phytomedicine 9 (2002): 515-522.
  7. Summary of Product Characteristics. Isentress 100 mg chewable tablets (2020).
  8. Summary of Product Characteristics. Singulair Paediatric 5 mg Chewable Tablets (2020).
  9. Srikumar R., et al. “Evaluation of the growth inhibitory activities of Triphala against common bacterial isolates from HIV infected patients”. Phytotherapy Research 21 (2007): 476-480.
  10. Singh I., et al. “Radioprotection of Swiss albino mice by Emblica officinalis”. Phytotherapy Research 19 (2005): 444-446.
  11. Sairam K., et al. “Antiulcerogenic effect of methanolic extract of Emblica officinalis: An experimental study”. Journal of Ethnopharmacology 82 (2002): 1-9.
  12. Bafna PA and Balaraman R. “Antioxidant activity of DHC 1, an herbal formulation, in experimentally induced cardiac and renal damage”. Phytotherapy Research 19 (2005): 216-221.
  13. Patil J., et al. “Formulation Development and Evaluation of Chewable Tablets Containing Non- Sedating Antihistamine”. Journal of Pharmaceutical and Scientific Innovation 3 (2012): 112-17.
  14. Fu Y., et al. “Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies”. Critical Reviews™ in Therapeutic Drug Carrier Systems 6 (2004): 433-475.
  15. Sohi H., et al. “Taste-masking technologies in oral pharmaceuticals: recent developments and approaches”. Drug Development and Industrial Pharmacy 5 (2004): 429-448.
  16. Lehamann K., et al. “Fast Disintegrating Controlled Release Tablets from Coated Particles”. Drugs Made in Germany2 (1994): 53-60.
  17. Solanki HK., et al. “Recent Advances in granulation technology”. International Journal of Pharmaceutical Sciences Review and Research3 (2010): 48-49.
  18. Ray C., et al. “Fast dissolving tablets-A Novel drug delivery system for pediatric and geriatric patient”. International Bulletin of Drug Research2 (2021): 55-70.
  19. Kathiresan K., et al. “Formulation and Evaluation of loratadine chewable tablets”. Research Journal of Pharmaceutical, Biological And Chemical Sciences4 (2010): 765.
  20. Zhang YJ., et al. “Antiproliferative activity of the main constituents from Phyllanthusemblica”. Biological and Pharmaceutical Bulletin 27 (2004): 251-255.
  21. Jeong SH and Park K. “Development of sustained release fast-disintegrating tablets using various polymer-coated ion-exchange resin complexes”. International Journal of Pharmaceutics 353 (2008): 195-204.

Citation

Citation: Gyanesh Kumar Sahu., et al. “Development of a Polyherbal Nutraceutical Chewable Tablet for Enhancing Skin Radiance and Hair Strength". Acta Scientific Pharmaceutical Sciences 9.4 (2025): 40-47.

Copyright

Copyright: © 2025 Gyanesh Kumar Sahu., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.

Contact US